<DOC>
	<DOCNO>NCT01857609</DOCNO>
	<brief_summary>This study aim investigate effect proton pump inhibitor pharmacokinetics pharmacodynamics metformin healthy Korean men .</brief_summary>
	<brief_title>Clinical Trial Investigate Effect Proton Pump Inhibitor Pharmacokinetics Pharmacodynamics Metformin</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>healthy male subject age 20 45 screen A body weight range 50 kg ( inclusive ) 100 kg ( inclusive ) ideal body weight range + 25 % subject decide participate voluntarily write informed consent form subject clinically significant disease cardiovascular , respiratory , renal , endocrinological , hematological , gastrointestinal , neurological ( central nervous system ) , psychiatric disorder malignant tumor Subject judge eligible study participation investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Proton pump inhibitor</keyword>
	<keyword>Drug interaction</keyword>
</DOC>